In the aromatase knockout (ArKO) mouse model of estrogen deficiency, hepatic steatosis occurs after six months of age, following the development of hepatic glucose intolerance, and can be reverted by estrogen treatment [147]. Here, CYP19A1 is linked to Glucose intolerance.